SCHEMBL14017683

SCHEMBL14017683

C[Si](C)(C)COC(=O)C(=CC=C(c1ccccc1)c1ccccc1)C(=O)OC[Si](C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.41
MEN1 O00255 2/20 0.41
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
LMNA P02545 4/20 0.36
MAPT P10636 4/20 0.36
ALDH1A1 P00352 4/20 0.36
TDP1 Q9NUW8 3/20 0.35
GAA P10253 1/20 0.35
KDM4E B2RXH2 3/20 0.35
HSP90AA1 P07900 2/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 3/20 0.34
POLB P06746 1/20 0.34
ATM Q13315 1/20 0.34
MAPK1 P28482 1/20 0.33
HIF1A Q16665 1/20 0.33
AKT1 P31749 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14017681 0.94 MEN1 (0.50) KMT2AMEN1LMNAMAPTALDH1A1
SCHEMBL14486187 0.87 MTNR1A (0.39) KMT2AMEN1MTNR1AMTNR1BLMNA
SCHEMBL14156332 0.83 MEN1 (0.60) KMT2AMEN1LMNAMAPTALDH1A1
SCHEMBL14017686 0.82 MAPT (0.41) KMT2AMEN1MAPTALDH1A1TDP1
SCHEMBL14135780 0.79 MEN1 (0.55) KMT2AMEN1LMNAMAPTALDH1A1
SCHEMBL1576936 0.79 KMT2A (0.41) KMT2AMEN1MTNR1AMTNR1BLMNA
SCHEMBL1576779 0.79 ALDH1A1 (0.50) KMT2AMEN1MTNR1AMTNR1BLMNA
SCHEMBL1576590 0.77 TSHR (0.48) MTNR1AMTNR1BLMNAMAPTTSHR
SCHEMBL13515676 0.77 MEN1 (0.57) KMT2AMEN1LMNAMAPTALDH1A1
SCHEMBL14017682 0.76 KMT2A (0.46) KMT2AMEN1LMNAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432386-B2 Diarylbutadiene-substituted methyltrialkylsilanes and photoprotective compositions comprised thereof L'OREAL (FR) 2008-10-07 US disclosed
US-20070213547-A1 For UV-photoprotecting human skin against the damaging effects of UV-radiation, notably UV-A radiation; example: monotrimethylsilanylmethyl monoethyl diester of (3,3-diphenyl-2-propylidene)propanedioic acid; good resistance to water and to perspiration L'OREAL 2007-09-13 US disclosed
US-7229609-B2 Diarylbutadiene-substituted methyltrialkylsilanes and photoprotective compositions comprised thereof L'OREAL (FR) 2007-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213547-A1 For UV-photoprotecting human skin against the damaging effects of UV-radiation, notably UV-A radiation; example: monotrimethylsilanylmethyl monoethyl diester of (3,3-diphenyl-2-propylidene)propanedioic acid; good resistance to water and to perspiration CUTA, DDB1, DCLRE1A KMT2A 2767/4885MEN1 1877/4885MTNR1A 1794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.